CHAIRMAN'S DESK

Chairman - The Kerala Group

Chairman & Founder

The Kerala Group

"Education is not merely about transferring knowledge; it is about building self-sustaining ecosystems where clinical precision, ethical leadership, and economic value thrive together."

Message From The Chairman

Welcome to The Kerala Group. When we established this institution in 2019, our objective was clear: to build an enduring educational foundation in Kerala that meets global healthcare standards and equips students with practical, industry-ready skills.

Starting with 55 students in our foundational batch, we have expanded to over 300 students at our flagship campus, Kerala Academy of Pharmacy (KAP) in Kandala, Near Kattakkada, Trivandrum. Our programs are fully recognized by the Pharmacy Council of India (PCI), AICTE New Delhi, DME, and affiliated with the Kerala University of Health Sciences (KUHS).

As healthcare demands rapidly evolve globally, we are entering our next phase of growth. We are expanding our academic campus to launch dedicated institutes in Nursing (BSc Nursing, GNM), Paramedical Sciences (BSc MLT, Radiography, Radiology), and Management Studies (MBA, BBA).

To our international partners, NRI investors, and strategic supporters—particularly through our International Promoter office in Abu Dhabi, UAE—we extend an invitation to participate in this expansion. We are committed to maintaining financial transparency, capital protection, and consistent annual ROI distributions while delivering world-class healthcare education.

Founder & Chairman

The Kerala Group, Trivandrum

Investor Desk →

Leadership Pillars

📜

Regulatory Compliance

All institutional programs operate under strict statutory approvals from PCI, AICTE, DME, and KUHS affiliation.

🏥

Clinical & Lab Infrastructure

Investments directed straight into advanced diagnostic equipment, chemistry labs, and practical training facilities.

📈

Investor Transparency

Structured 5-year investment contracts featuring guaranteed annual profit sharing from 20% to 25% ROI.